Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 130 Records) |
Query Trace: Thyroid Neoplasms and RET[original query] |
---|
Genetic Variants Associated with Thyroid Cancer Risk: Comprehensive Research Synopsis, Meta-Analysis, and Cumulative Epidemiological Evidence. Journal of oncology 2021 12 2021 9967599. Ran Ran, Tu Gang, Li Hui, Wang Hao, Mou Exian, Liu Caiya |
Medullary thyroid cancer with RET V804M mutation: more indolent than expected? Surgery 2022 9 173 (1): 260-267. Frisco Nicholas A, Gunn Alexander H, Thomas Samantha M, Stang Michael T, Scheri Randall P, Kazaure Hadiza |
Sporadic medullary thyroid cancer: a systematic review and meta-analysis of clinico-pathological and mutational characteristics predicting recurrence. Thyroid research 2022 7 15 (1): 12. Cosway Benjamin, Fussey Jonathan, Kim Dae, Wykes James, Elliott Michael, Smith Jo |
Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common. International journal of pediatric otorhinolaryngology 2022 4 157 111121. Newfield Ron S, Jiang Wen, Sugganth Daniel X, Hantash Feras M, Lee Euyhyun, Newbury Robert |
Pre- and Post-operative Circulating Tumoral DNA in Patients With Medullary Thyroid Carcinoma. The Journal of clinical endocrinology and metabolism 2022 4 107 (8): e3420-e3427. Ciampi Raffaele, Romei Cristina, Ramone Teresa, Matrone Antonio, Prete Alessandro, Gambale Carla, Materazzi Gabriele, De Napoli Luigi, Torregrossa Liborio, Basolo Fulvio, Castagna Maria Grazia, Brilli Lucia, Ferretti Elisabetta, Elisei Rossel |
RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype. Annals of surgical oncology 2022 3 . Ullmann Timothy M, Thiesmeyer Jessica W, Lee Yeon Joo, Beg Shaham, Mosquera Juan Miguel, Elemento Olivier, Fahey Thomas J, Scognamiglio Theresa, Houvras Yar |
Genetic and Clinicopathologic Characteristics of Papillary Thyroid Carcinoma in the Chinese Population: High BRAF Mutation Allele Frequency, Multiple Driver Gene Mutations, and RET Fusion May Indicate More Advanced TN Stage. OncoTargets and therapy 2022 2 15 147-157. Wang Zhihong, Tang Peng, Hua Surong, Gao Junyi, Zhang Bin, Wan Hua, Wu Qixi, Zhang Jiaxin, Chen |
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma. Frontiers in oncology 2022 12 12 1042525. Nannini Margherita, Repaci Andrea, Ricco Gianluca, Ianni Manuela, Golemi Arber, Maiolo Vincenzo, Ferrari Marco, Natali Filippo, Rizzini Elisa Lodi, Monari Fabio, Solaroli Erica, De Leo Antonio, Maloberti Thais, Pantaleo Maria A, De Biase Dario, Tallini Giovan |
Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers. European thyroid journal 2022 1 11 (1): . Eszlinger Markus, Stewardson Paul, McIntyre John B, Box Adrian, Khalil Moosa, Hyrcza Martin, Koro Konstantin, Ruether Dean, Wu Jiahui, Paschke Ra |
Molecular profiling of papillary thyroid carcinomas in healthcare workers exposed to low dose radiation at the workplace. Endocrine 2022 Jan . Duque Carlos S, Vélez Alejandro, Cuartas Jorge, Jaimes Fabian, Dueñas Juan Pablo, Agudelo Miguel, Nikiforova Marina N, Nikiforov Yuri E, Condello Vincen |
Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric Thyroid Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 1 40 (10): 1081-1090. Franco Aime T, Ricarte-Filho Julio C, Isaza Amber, Jones Zachary, Jain Neil, Mostoufi-Moab Sogol, Surrey Lea, Laetsch Theodore W, Li Marilyn M, DeHart Jessica Clague, Reichenberger Erin, Taylor Deanne, Kazahaya Ken, Adzick N Scott, Bauer Andrew |
Genomic Profiling of Aggressive Thyroid Cancer in Association With its Clinicopathological Characteristics. In vivo (Athens, Greece) 2022 1 36 (1): 111-120. Kim Jae-Hui, Jeong Ji Yun, Seo An Na, Park Nora Jee-Young, Kim Moonsik, Park Ji You |
RET fusion genes in pediatric and adult thyroid carcinomas: cohort characteristics and prognosis. Endocrine-related cancer 2023 9 . Barbora Bulanova Pekova, Vlasta Sykorova, Karolina Mastnikova, Eliska Vaclavikova, Jitka Moravcova, Petr Vlcek, Lucie Lancova, Petr Lastuvka, Rami Katra, Petr Bavor, Daniela Kodetova, Martin Chovanec, Jana Drozenova, Radoslav Matej, Jaromir Astl, Jiri Hlozek, Petr Hrabal, Josef Vcelak, Bela Bendlo |
Mutational profiling of Chinese patients with thyroid cancer. Frontiers in endocrinology 2023 7 14 1156999. Yaying Du, Shu Zhang, Gang Zhang, Jiaying Hu, Lianhua Zhao, Yuanyuan Xiong, Lu Shen, Rongrong Chen, Ke Ye, Yan |
Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype. Frontiers in endocrinology 2023 5 14 1138100. Jie Zhou, Wei-Ran Wang, Hui-Fang Zhang, Qi-Qi Gao, Wei-Bin Wang, Jian-Hua Zhu, Yu-Shuai Han, Jing Chen, Tong-Hui Ma, Xiao-Yan Zhang, Xiao-Dong Te |
Landscape of gene mutation in Chinese thyroid cancer patients: Construction and validation of lymph node metastasis prediction model based on clinical features and gene mutation marker. Cancer medicine 2023 4 . Meng Wei, Rui Wang, Wanxue Zhang, Jing Zhang, Qiang Fang, Zheng Fang, Bin Liu, Yongxiang |
Molecular genetics of diffuse sclerosing papillary thyroid cancer. The Journal of clinical endocrinology and metabolism 2023 3 . Alswailem Meshael, Alghamdi Balgees, Alotaibi Anwar, Aljomiah Abeer, Al-Hindi Hindi, Murugan Avaniyapuram Kannan, Abouelhoda Mohamed, Shi Yufei, Alzahrani Ali |
Childhood Exposure to Excess Ionizing Radiation Is Associated with Dose-Dependent Fusions as Molecular Drivers of Papillary Thyroid Cancer. Clinical thyroidology 2023 3 34 (4): 161-164. Klubo-Gwiezdzinska Joan |
[Hereditary medullary thyroid cancer]. Chirurgie (Heidelberg, Germany) 2023 2 . Fendrich V, Zahn |
Familial parathyroid tumours-comparison of clinical profiles between syndromes. Journal of endocrinological investigation 2023 2 . Figueiredo A A, Saramago A, Cavaco B M, Simões-Pereira J, Leite |
The frequency of mutations in advanced thyroid cancer in Japan: a single-center study. Endocrine journal 2023 12 . Soji Toda, Hiroyuki Iwasaki, Yoichiro Okubo, Hiroyuki Hayashi, Mei Kadoya, Hiroyuki Takahashi, Tomoyuki Yokose, Yukihiko Hiroshima, Katsuhiko Masu |
Clinical and molecular characterisation of metastatic papillary thyroid cancer according to radioiodine therapy outcomes. Endocrine 2023 12 . Joana Simões-Pereira, Ana Saramago, Ricardo Rodrigues, Marta Pojo, Carolina Pires, Mariana Horta, Dolores López-Presa, Miguel Rito, Rafael Cabrera, Teresa C Ferreira, Valeriano Leite, Branca M Cava |
Clinical characteristics of a large familial cohort with Medullary thyroid cancer and germline Cys618Arg RET mutation in an Israeli multicenter study. Frontiers in endocrinology 2023 11 14 1268193. Rachel Chava Rosenblum, Dania Hirsch, Simona Grozinsky-Glasberg, Carlos Benbassat, Uri Yoel, Avraham Ishay, Sagit Zolotov, Gideon Bachar, Ehud Banne, Sigal Levy, Orit Twi |
RET fusion genes in pediatric and adult thyroid carcinomas: cohort characteristics and prognosis. Endocrine-related cancer 2023 10 30 (12): . Barbora Bulanova Pekova, Vlasta Sykorova, Karolina Mastnikova, Eliska Vaclavikova, Jitka Moravcova, Petr Vlcek, Lucie Lancova, Petr Lastuvka, Rami Katra, Petr Bavor, Daniela Kodetova, Martin Chovanec, Jana Drozenova, Radoslav Matej, Jaromir Astl, Jiri Hlozek, Petr Hrabal, Josef Vcelak, Bela Bendlo |
Genetic and clinical profiles of 160 papillary thyroid cancers with lateral neck lymph node metastasis. Frontiers in oncology 2023 1 12 1057532. Fang Yiqiao, Zheng Xun, Zou Xiuhe, Ye Zi, Liu Jiaye, Lei Jianyong, Li Zhih |
Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks. Nature communications 2024 4 15 (1): 3175. Ning Qu, Di Chen, Ben Ma, Lijun Zhang, Qiuping Wang, Yuting Wang, Hongping Wang, Zhaoxian Ni, Wen Wang, Tian Liao, Jun Xiang, Yulong Wang, Shi Jin, Dixin Xue, Weili Wu, Yu Wang, Qinghai Ji, Hui He, Hai-Long Piao, Rongliang S |
BRAF and RET polymorphism association with thyroid cancer risk, a preliminary study from Khyber Pakhtunkhwa population. Molecular biology reports 2024 4 51 (1): 502. Maryam Batool, Najeeb Ullah Khan, Hamza Khan, Mikhlid H Almutairi, Ijaz Ali, Brian D Ada |
TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Advances in therapy 2024 1 . Sergio D Cruz-Romero, Sebastián González, José Y Juez, David S Becerra, Ana M Baldión, José A Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A Rodríguez-Urre |
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients. Endocrine-related cancer 2024 1 . Xiangqian Zheng, Meiyu Fang, Yun Fan, Yuping Sun, Meili Sun, Ankui Yang, Bin Zhang, Qinjiang Liu, Hui Liu, Xiaohong Zhou, Tao Huang, Jianwu Qin, Zhaohui Wang, Mengmeng Qin, Zhenwei Shen, Sheng Yao, Jason Yang, Yu Wang, Ming G |
Genetic predisposition to differentiated thyroid cancer among Polish population. Polish archives of internal medicine 2024 1 . Martyna Borowczyk, Mateusz Sypniewski, Joanna Szyda, Ma?gorzata Braszka, Katarzyna Ziemnicka, Marek Rucha?a, Michalina Oszywa, Zbigniew J Król, Paula Dobo |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: